Safety of COVID-19 Vaccines among Patients with Type 2 Diabetes Mellitus: Real-World Data Analysis ( 2023;47:356-65)

Safety of COVID-19 Vaccines among Patients with Type 2 Diabetes Mellitus: Real-World Data Analysis ( 2023;47:356-65)

Bibliographic Details
Main Author:	Jung Hun Ohn
Format:	Article
Language:	English
Published:	Korean Diabetes Association 2023-09-01
Series:	Diabetes & Metabolism Journal
Online Access:	http://www.e-dmj.org/upload/pdf/dmj-2023-0269.pdf

Similar Items

Safety of COVID-19 Vaccines among Patients with Type 2 Diabetes Mellitus: Real-World Data Analysis ( 2023;47:356-65)
by: Hye Jun Kim, et al.
Published: (2023-09-01)

Altered Metabolic Phenotypes and Hypothalamic Neuronal Activity Triggered by Sodium-Glucose Cotransporter 2 Inhibition (Diabetes Metab J 2023;47:784-95)
by: Ho Gyun Lee, et al.
Published: (2024-01-01)

Altered Metabolic Phenotypes and Hypothalamic Neuronal Activity Triggered by Sodium-Glucose Cotransporter 2 Inhibition (Diabetes Metab J 2023;47:784-95)
by: Jae Hyun Bae
Published: (2024-01-01)

Association of Body Mass Index and Fracture Risk Varied by Affected Bones in Patients with Diabetes: A Nationwide Cohort Study ( 2023;47:242-54)
by: Se-Won Lee, et al.
Published: (2023-05-01)

Association of Body Mass Index and Fracture Risk Varied by Affected Bones in Patients with Diabetes: A Nationwide Cohort Study ( 2023;47:242-54)
by: So Young Park
Published: (2023-05-01)

Risk of Diabetic Retinopathy between Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists (Diabetes Metab J 2023;47:394-404)
by: Tzu-Yi Lin, et al.
Published: (2023-07-01)

Risk of Diabetic Retinopathy between Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists (Diabetes Metab J 2023;47:394-404)
by: Jihee Ko, et al.
Published: (2023-07-01)

Association of Myosteatosis with Nonalcoholic Fatty Liver Disease, Severity, and Liver Fibrosis Using Visual Muscular Quality Map in Computed Tomography (Diabetes Metab J 2023;47:104-17)
by: Hwi Seung Kim, et al.
Published: (2023-03-01)

Response: Eccentric Versus Concentric Exercises in Patients With Rheumatoid Arthritis and Rotator Cuff Tendinopathy: A Randomized Comparative Study ( 2023;47:26-35)
by: Mina Magdy Wahba, et al.
Published: (2024-02-01)

Association of Myosteatosis with Nonalcoholic Fatty Liver Disease, Severity, and Liver Fibrosis Using Visual Muscular Quality Map in Computed Tomography (Diabetes Metab J 2023;47:104-17)
by: Eun Roh
Published: (2023-03-01)

Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial ( 2023;47:668-81)
by: Da Young Lee
Published: (2023-11-01)

Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial ( 2023;47:668-81)
by: Nikolai N. Scherbak, et al.
Published: (2023-11-01)

Safety of COVID-19 Vaccines among Patients with Type 2 Diabetes Mellitus: Real-World Data Analysis
by: Hye Jun Kim, et al.
Published: (2023-05-01)

Re: Daniel D. Joyce, Matteo Soligo, Alessandro Morlacco, et al. Effect of Preoperative Multiparametric Magnetic Resonance Imaging on Oncologic and Functional Outcomes Following Radical Prostatectomy. Eur Urol Open Sci 2023;47:87–93
by: Zafer Tandogdu, et al.
Published: (2023-06-01)

Autoantibodies to GAD65 and IA-2 in canine diabetes mellitus.
by: Davison, L, et al.
Published: (2008)

Management of the Diabetic Foot in People with Diabetes Mellitus Older than 65 Years
by: Álvaro Astasio-Picado, et al.
Published: (2022-10-01)

A Real-World Study of Long-Term Safety and Efficacy of Lobeglitazone in Korean Patients with Type 2 Diabetes Mellitus
by: Bo-Yeon Kim, et al.
Published: (2022-11-01)

2023 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association
by: Jong Han Choi, et al.
Published: (2023-09-01)

Quality of diabetes mellitus therapy in patients with chronic kidney disease in the real world
by: Beatrice Giampietro, et al.
Published: (2017-03-01)

Psychosocial factors in adherence to pharmacological treatment and diabetes mellitus control in patients over 65
by: Alfredo Lara-Morales, et al.
Published: (2022-05-01)

Current vaccination status and safety of children with peripheral neuroblastoma in the real-world
by: Heping Shen, et al.
Published: (2024-01-01)

The post-authorisation safety of COVID-19 vaccines: real-world evidence
by: Li, X
Published: (2024)

Efficacy and Safety of Empagliflozin in Patients with Type 2 Diabetes Mellitus Fasting During Ramadan: A Real-World Study from Bangladesh
by: Pathan MF, et al.
Published: (2022-12-01)

Gastroparesis might not be uncommon in patients with diabetes mellitus in a real-world clinical setting: a cohort study
by: Jeongmin Lee, et al.
Published: (2024-01-01)

Vaccination of patients with diabetes mellitus
by: M. V. Shestakova, et al.
Published: (2022-03-01)

Semaglutide Effects on Metabolic Outcomes in Diabetes Mellitus Patients — Real World Study
by: Balcázar-Valencia CM, et al.
Published: (2024-04-01)

Lorenzoni, F. (2023). Educare controvento. Storie di maestri e maestre ribelli. Sellerio. 356 p.
by: Lara Magrini
Published: (2023-09-01)

Real-World Evidence in Cost-Effectiveness Analysis of Enhanced Influenza Vaccines in Adults ≥ 65 Years of Age: Literature Review and Expert Opinion
by: Maarten Postma, et al.
Published: (2023-06-01)

Efficacy and safety of canagliflozin 300 mg in overweight and obese type 2 diabetes mellitus patients in a real-world setting: COLOR study
by: Pankaj Aneja, et al.
Published: (2019-01-01)

Effectiveness and safety of recombinant zoster vaccine: A review of real-world evidence
by: Raunak Parikh, et al.
Published: (2023-12-01)

Real-world adherence to toxicity management guidelines for immune checkpoint inhibitor-induced diabetes mellitus
by: Min Shen, et al.
Published: (2023-07-01)

Progression from prediabetes to type 2 diabetes mellitus in adolescents: a real world experience
by: Alyson Weiner, et al.
Published: (2023-05-01)

Durability of glucose-lowering effect of dulaglutide in patients with type 2 diabetes mellitus: A real-world data study
by: Hwi Seung Kim, et al.
Published: (2022-10-01)

Safety and immunogenicity of a quadrivalent influenza vaccine in adults 65 y of age and older
by: David P. Greenberg, et al.
Published: (2017-09-01)

Peptide Vaccines for Hypertension and Diabetes Mellitus
by: Hironori Nakagami, et al.
Published: (2014-11-01)

Self-Reported Real-World Safety and Reactogenicity of COVID-19 Vaccines: A Vaccine Recipient Survey
by: Alexander G. Mathioudakis, et al.
Published: (2021-03-01)

Perception and safety analysis of COVID‐19 vaccination in cancer patients: A multicenter, real‐world study
by: Kyoungmin Lee, et al.
Published: (2023-03-01)

Real-World Clinical Outcomes Associated with Canagliflozin in Patients with Type 2 Diabetes Mellitus in Spain: The Real-Wecan Study
by: Juan J. Gorgojo-Martínez, et al.
Published: (2020-07-01)

Iz Evripidovega Oresta (356–629)
by: Jera Ivanc
Published: (2010-12-01)

Immunogenicity, safety, and effectiveness of seasonal influenza vaccination in patients with diabetes mellitus: A systematic review
by: Gael Dos Santos, et al.
Published: (2018-08-01)